2024-01-01 12532150 2025-02-10 12532150 2024-01-01 2025-02-10 12532150 2023-12-31 12532150 2023-01-01 2023-12-31 12532150 uk-core:WithinOneYear 2023-12-31 12532150 uk-core:WithinOneYear 2025-02-10 12532150 uk-core:AfterOneYear 2023-12-31 12532150 uk-core:AfterOneYear 2025-02-10 12532150 uk-bus:Director1 2024-01-01 2025-02-10 iso4217:GBP xbrli:pure 12532150 uk-bus:AuditExemptWithAccountantsReport 2024-01-01 2025-02-10 12532150 uk-bus:Micro-entities 2024-01-01 2025-02-10 12532150 uk-bus:FullAccounts 2024-01-01 2025-02-10 12532150 uk-bus:PrivateLimitedCompanyLtd 2024-01-01 2025-02-10
GREENVILLE BIO CONSULTANCY LTD
Registered Number:12532150
For the period ended 10 February 2025
England and Wales
Unaudited Financial Statements
2
For the period ended 10 February 2025
GREENVILLE BIO CONSULTANCY LTD
Contents Page
1 to 2
Statement of Financial Position and Notes to the Accounts
3
12532150
Registered Number :
As at 10 February 2025
GREENVILLE BIO CONSULTANCY LTD
Statement of Financial Position and Notes to the Accounts
£
£
2023
2025
£
£
30,142
30,142
Fixed assets
936
40,204
Current assets
Creditors: amounts falling due
within one year
(2,551)
285
37,653
1,221
Net current assets
Total assets less current liabilities
31,363
67,795
Creditors: amounts falling due
after more than one year
(25,152)
-
Accruals and deferred income
(800)
(800)
30,563
Net assets
41,843
30,563
41,843
Capital and reserves
Notes to the Accounts
Statutory Information
GREENVILLE BIO CONSULTANCY LTD is a private limited company, limited by shares, domiciled in England and
Wales, registration number 12532150.
Registered address:
103 WELLDON CRESCENT
HARROW
MIDDLESEX
HA1 1QW
The presentation currency is £ sterling.
1. Average number of persons employed
During the year the average number of employees was 0 (2023 : 1)
1 of 2
4
12532150
Registered Number :
For the period ended 10 February 2025
GREENVILLE BIO CONSULTANCY LTD
Statement of Financial Position and Notes to the Accounts Continued
For the period ended 10 February 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the period ended 10 February 2025 in accordance with Section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
These financial statements have been prepared in accordance with the micro-entities provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
SEYER NOMONI Director
These financial statements were approved and authorised for issue by the Board on 11 February 2025 and were signed by:
2 of 2